| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microtubule motor activity | 1.00e-06 | 70 | 220 | 8 | GO:0003777 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | CPAMD8 SERPINA1 SERPINA4 SERPINE2 COL6A3 SERPINA11 SERPINA10 SERPINA5 | 2.13e-05 | 105 | 220 | 8 | GO:0004867 |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | CPAMD8 CFTR ELFN2 IQGAP1 SLIT2 SERPINA1 SERPINA4 SERPINE2 STOML1 C5 TAF1L COL6A3 FRAT1 SERPINA11 ZNF451 SERPINA10 DKKL1 SERPINA5 PPP1R16A | 3.56e-05 | 596 | 220 | 19 | GO:0140678 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.95e-05 | 118 | 220 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | CPAMD8 ACRBP SERPINA1 SERPINA4 SERPINE2 NOD1 C5 COL6A3 SERPINA11 SERPINA10 SERPINA5 | 1.38e-04 | 257 | 220 | 11 | GO:0061134 |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | CPAMD8 SERPINA1 SERPINA4 SERPINE2 C5 COL6A3 SERPINA11 SERPINA10 SERPINA5 | 1.78e-04 | 180 | 220 | 9 | GO:0004866 |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | CPAMD8 SERPINA1 SERPINA4 SERPINE2 C5 COL6A3 SERPINA11 SERPINA10 SERPINA5 | 2.37e-04 | 187 | 220 | 9 | GO:0030414 |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | CPAMD8 SERPINA1 SERPINA4 SERPINE2 C5 COL6A3 SERPINA11 SERPINA10 SERPINA5 | 4.03e-04 | 201 | 220 | 9 | GO:0061135 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA13 CFTR ABCA9 DDX11 KIF9 DHX35 DNAH9 KIF6 KIF21A RNF213 KIF20A DNAH12 MACF1 POLQ | 4.03e-04 | 441 | 220 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA13 CFTR ABCA9 DDX11 KIF9 STARD9 DHX35 DNAH9 KIF6 KIF21A RNF213 DNAH1 KIF20A MSH6 DNAH12 MACF1 POLQ | 4.82e-04 | 614 | 220 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 9.53e-04 | 18 | 220 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SPTA1 SPATA31A7 SPATA31A6 IQGAP1 KIF9 MRTFB KCNA5 STARD9 DIAPH1 PLS1 TBCD KIF6 RAB25 SPATA31A3 KIF21A FHOD3 RELA SPATA31A5 KIF20A RGS14 SPATA31A1 FHOD1 MACF1 NIN | 1.10e-03 | 1099 | 220 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | CPAMD8 ELFN2 IQGAP1 SLIT2 SERPINA1 SERPINA4 SERPINE2 C5 COL6A3 SERPINA11 SERPINA10 SERPINA5 PPP1R16A | 1.12e-03 | 435 | 220 | 13 | GO:0004857 |
| GeneOntologyMolecularFunction | integrin binding involved in cell-matrix adhesion | 1.18e-03 | 5 | 220 | 2 | GO:0098640 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ADCY10 TRIO CDH23 TENM2 SLIT2 NEO1 BRAF GORASP1 CNTN5 DIAPH1 SEMA4A ROBO3 PLS1 TBCD STK25 OBSL1 SIAH1 LAMC2 SPG11 ZDHHC17 SEMA3D MACF1 EPHA10 ARHGAP33 LGI1 NIN | 1.52e-07 | 748 | 222 | 26 | GO:0048667 |
| GeneOntologyBiologicalProcess | axonogenesis | ADCY10 TRIO TENM2 SLIT2 NEO1 BRAF CNTN5 DIAPH1 SEMA4A ROBO3 STK25 SIAH1 LAMC2 SPG11 ZDHHC17 SEMA3D MACF1 EPHA10 LGI1 NIN | 3.51e-06 | 566 | 222 | 20 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ADCY10 TRIO SPTA1 CDH23 TENM2 IQGAP1 SLIT2 NEO1 BRAF GORASP1 CNTN5 DIAPH1 SEMA4A ROBO3 PLS1 TBCD STK25 COL6A1 RAB25 OBSL1 SIAH1 LAMC2 SPG11 ZDHHC17 SEMA3D LIPA MACF1 EPHA10 ARHGAP33 LGI1 NIN | 4.92e-06 | 1194 | 222 | 31 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ADCY10 TRIO TENM2 IQGAP1 SLIT2 NEO1 BRAF GORASP1 CNTN5 DIAPH1 SEMA4A ROBO3 STK25 OBSL1 SIAH1 LAMC2 SPG11 ZDHHC17 SEMA3D MACF1 EPHA10 ARHGAP33 LGI1 NIN | 6.34e-06 | 802 | 222 | 24 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ADCY10 TRIO TENM2 IQGAP1 SLIT2 NEO1 BRAF GORASP1 CNTN5 DIAPH1 SEMA4A ROBO3 STK25 OBSL1 SIAH1 LAMC2 SPG11 ZDHHC17 SEMA3D MACF1 EPHA10 ARHGAP33 LGI1 NIN | 9.00e-06 | 819 | 222 | 24 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ADCY10 TRIO TENM2 IQGAP1 SLIT2 NEO1 BRAF GORASP1 CNTN5 DIAPH1 SEMA4A ROBO3 STK25 OBSL1 SIAH1 LAMC2 SPG11 ZDHHC17 SEMA3D MACF1 EPHA10 ARHGAP33 LGI1 NIN | 1.04e-05 | 826 | 222 | 24 | GO:0048858 |
| GeneOntologyBiologicalProcess | axon guidance | TRIO TENM2 SLIT2 NEO1 CNTN5 DIAPH1 SEMA4A ROBO3 SIAH1 LAMC2 SEMA3D EPHA10 LGI1 | 1.39e-05 | 285 | 222 | 13 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | TRIO TENM2 SLIT2 NEO1 CNTN5 DIAPH1 SEMA4A ROBO3 SIAH1 LAMC2 SEMA3D EPHA10 LGI1 | 1.44e-05 | 286 | 222 | 13 | GO:0097485 |
| GeneOntologyBiologicalProcess | axon development | ADCY10 TRIO TENM2 SLIT2 NEO1 BRAF CNTN5 DIAPH1 SEMA4A ROBO3 STK25 SIAH1 LAMC2 SPG11 ZDHHC17 SEMA3D MACF1 EPHA10 LGI1 NIN | 2.21e-05 | 642 | 222 | 20 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | TRIP6 TMEM8B VIT ITGAD IQGAP1 BRAF ADAMTS9 MERTK TBCD GP5 EMILIN1 SLC9A1 MACF1 MUC4 MADCAM1 | 4.08e-05 | 410 | 222 | 15 | GO:0031589 |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 9.85e-05 | 9 | 222 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | centrosome-templated microtubule nucleation | 1.15e-04 | 2 | 222 | 2 | GO:0090222 | |
| GeneOntologyBiologicalProcess | neuron projection development | ADCY10 TRIO CDH23 TENM2 IQGAP1 SLIT2 NEO1 SERPINE2 MRTFB BRAF GORASP1 CNTN5 DIAPH1 SEMA4A ROBO3 PLS1 STK25 DPYSL2 OBSL1 SIAH1 LAMC2 SPG11 ZDHHC17 SEMA3D MACF1 EPHA10 ARHGAP33 LGI1 NIN | 1.28e-04 | 1285 | 222 | 29 | GO:0031175 |
| GeneOntologyBiologicalProcess | corticospinal tract morphogenesis | 1.40e-04 | 10 | 222 | 3 | GO:0021957 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | TRIP6 TMEM8B ITGAD IQGAP1 ADAMTS9 GP5 EMILIN1 SLC9A1 MACF1 MUC4 MADCAM1 | 1.74e-04 | 270 | 222 | 11 | GO:0007160 |
| GeneOntologyCellularComponent | microtubule | IQGAP1 KIF9 DNAH9 TBCD DPYSL2 KIF6 KIF21A KCNAB2 DNAH1 KIF20A RGS14 DNAH12 NINL MACF1 SPAG17 PCNT NIN | 5.93e-05 | 533 | 222 | 17 | GO:0005874 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 9.47e-05 | 9 | 222 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | collagen type VI trimer | 3.34e-04 | 3 | 222 | 2 | GO:0005589 | |
| GeneOntologyCellularComponent | collagen beaded filament | 3.34e-04 | 3 | 222 | 2 | GO:0098647 | |
| GeneOntologyCellularComponent | acrosomal vesicle | ACRBP SPATA31A7 SPATA31A6 SPATA31A3 SPATA31A5 SPATA31A1 SPAG17 DKKL1 SERPINA5 | 3.70e-04 | 206 | 222 | 9 | GO:0001669 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 3.94e-04 | 14 | 222 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | supramolecular fiber | RYR3 IQGAP1 KIF9 KCNA5 DIAPH1 DNAH9 PLS1 TBCD COL6A1 COL6A3 DPYSL2 KIF6 KIF21A KCNAB2 OBSL1 FHOD3 DNAH1 KIF20A RGS14 DNAH12 NINL MACF1 SPAG17 PCNT NIN | 7.85e-04 | 1179 | 222 | 25 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | RYR3 IQGAP1 KIF9 KCNA5 DIAPH1 DNAH9 PLS1 TBCD COL6A1 COL6A3 DPYSL2 KIF6 KIF21A KCNAB2 OBSL1 FHOD3 DNAH1 KIF20A RGS14 DNAH12 NINL MACF1 SPAG17 PCNT NIN | 8.64e-04 | 1187 | 222 | 25 | GO:0099081 |
| Domain | 7-in-absentia-prot_TRAF-dom | 1.50e-06 | 3 | 215 | 3 | IPR018121 | |
| Domain | Sina | 1.50e-06 | 3 | 215 | 3 | PF03145 | |
| Domain | Serpin_dom | 3.17e-06 | 36 | 215 | 6 | IPR023796 | |
| Domain | SERPIN | 3.75e-06 | 37 | 215 | 6 | PS00284 | |
| Domain | SERPIN | 3.75e-06 | 37 | 215 | 6 | SM00093 | |
| Domain | Serpin | 4.40e-06 | 38 | 215 | 6 | PF00079 | |
| Domain | - | KCTD9 FBXL13 LRRC4 STK11IP ELFN2 SLIT2 NOD1 NLRC5 FBXO33 GP5 LGR5 NLRP9 CMIP LRRC15 LGI1 | 4.97e-06 | 321 | 215 | 15 | 3.80.10.10 |
| Domain | Serpin_fam | 5.16e-06 | 39 | 215 | 6 | IPR000215 | |
| Domain | P-loop_NTPase | ADCY10 ABCA13 CFTR ABCA9 IQGAP1 DDX11 KIF9 NOD1 STARD9 NLRC5 DHX35 DNAH9 GNL3 KIF6 NWD1 RAB25 KIF21A RNF213 DNAH1 KIF20A MSH6 NLRP9 DNAH12 RASL11A IQCB1 POLQ | 5.32e-06 | 848 | 215 | 26 | IPR027417 |
| Domain | DUF2012 | 5.97e-06 | 4 | 215 | 3 | PF09430 | |
| Domain | SINA-like | 5.97e-06 | 4 | 215 | 3 | IPR004162 | |
| Domain | DUF2012 | 5.97e-06 | 4 | 215 | 3 | IPR019008 | |
| Domain | L_dom-like | KCTD9 FBXL13 LRRC4 STK11IP ELFN2 SLIT2 NOD1 NLRC5 FBXO33 GP5 LGR5 NLRP9 CMIP LRRC15 LGI1 | 6.44e-06 | 328 | 215 | 15 | IPR032675 |
| Domain | DUF4599 | 7.86e-06 | 12 | 215 | 4 | PF15371 | |
| Domain | DUF4599 | 7.86e-06 | 12 | 215 | 4 | IPR027970 | |
| Domain | ARM-type_fold | NBEAL1 UNC45A RYR3 AP2B1 TELO2 DIAPH1 BRAT1 TBCD ARMC6 DOCK8 FHOD3 PPP6R1 WDFY4 FHOD1 IQCB1 | 9.56e-06 | 339 | 215 | 15 | IPR016024 |
| Domain | ZF_SIAH | 1.48e-05 | 5 | 215 | 3 | PS51081 | |
| Domain | RBD | 2.93e-05 | 6 | 215 | 3 | PF02196 | |
| Domain | CarboxyPept-like_regulatory | 3.61e-05 | 17 | 215 | 4 | IPR008969 | |
| Domain | RBD | 5.09e-05 | 7 | 215 | 3 | SM00455 | |
| Domain | RBD_dom | 5.09e-05 | 7 | 215 | 3 | IPR003116 | |
| Domain | RBD | 5.09e-05 | 7 | 215 | 3 | PS50898 | |
| Domain | Ig-like_fold | TRIO LRRC4 NEO1 NFATC3 NOMO2 CNTN5 SEMA4A ROBO3 MERTK IL23R COL6A3 OBSL1 RELA ADAMTSL3 NOMO1 SEMA3D TIGIT MADCAM1 ALPK2 NOMO3 EPHA10 | 6.97e-05 | 706 | 215 | 21 | IPR013783 |
| Domain | Leu-rich_rpt | FBXL13 LRRC4 STK11IP ELFN2 SLIT2 NOD1 NLRC5 GP5 LGR5 NLRP9 LRRC15 LGI1 | 7.50e-05 | 271 | 215 | 12 | IPR001611 |
| Domain | Carb-bd-like_fold | 8.07e-05 | 8 | 215 | 3 | IPR013784 | |
| Domain | - | TRIO LRRC4 NEO1 NFATC3 NOMO2 CNTN5 ROBO3 MERTK IL23R COL6A3 OBSL1 RELA ADAMTSL3 NOMO1 SEMA3D TIGIT MADCAM1 ALPK2 NOMO3 EPHA10 | 8.62e-05 | 663 | 215 | 20 | 2.60.40.10 |
| Domain | Kinesin_motor_CS | 1.03e-04 | 41 | 215 | 5 | IPR019821 | |
| Domain | GSK3-bd | 1.32e-04 | 2 | 215 | 2 | IPR008014 | |
| Domain | GSK-3_bind | 1.32e-04 | 2 | 215 | 2 | PF05350 | |
| Domain | - | 1.45e-04 | 44 | 215 | 5 | 3.40.850.10 | |
| Domain | Kinesin | 1.45e-04 | 44 | 215 | 5 | PF00225 | |
| Domain | KISc | 1.45e-04 | 44 | 215 | 5 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.45e-04 | 44 | 215 | 5 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.45e-04 | 44 | 215 | 5 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.45e-04 | 44 | 215 | 5 | PS50067 | |
| Domain | GBD/FH3_dom | 2.32e-04 | 11 | 215 | 3 | IPR014768 | |
| Domain | GBD_FH3 | 2.32e-04 | 11 | 215 | 3 | PS51232 | |
| Domain | FN3 | 3.00e-04 | 185 | 215 | 9 | SM00060 | |
| Domain | ARM-like | UNC45A AP2B1 TELO2 BRAT1 TBCD ARMC6 DOCK8 FHOD3 WDFY4 FHOD1 IQCB1 | 3.07e-04 | 270 | 215 | 11 | IPR011989 |
| Domain | Ig_I-set | 3.65e-04 | 190 | 215 | 9 | IPR013098 | |
| Domain | I-set | 3.65e-04 | 190 | 215 | 9 | PF07679 | |
| Domain | CarboxyPept_regulatory_dom | 3.95e-04 | 13 | 215 | 3 | IPR014766 | |
| Domain | - | 3.95e-04 | 13 | 215 | 3 | 2.60.40.1120 | |
| Domain | Serpin_CS | 4.77e-04 | 32 | 215 | 4 | IPR023795 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.99e-04 | 14 | 215 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 4.99e-04 | 14 | 215 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.99e-04 | 14 | 215 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.99e-04 | 14 | 215 | 3 | IPR011704 | |
| Domain | - | 4.99e-04 | 14 | 215 | 3 | 2.60.210.10 | |
| Domain | AAA_8 | 4.99e-04 | 14 | 215 | 3 | PF12780 | |
| Domain | AAA_5 | 4.99e-04 | 14 | 215 | 3 | PF07728 | |
| Domain | FN3 | 5.12e-04 | 199 | 215 | 9 | PS50853 | |
| Domain | Cys-rich_flank_reg_C | 6.05e-04 | 90 | 215 | 6 | IPR000483 | |
| Domain | LRRCT | 6.05e-04 | 90 | 215 | 6 | SM00082 | |
| Domain | DHC_fam | 6.18e-04 | 15 | 215 | 3 | IPR026983 | |
| Domain | FH2 | 6.18e-04 | 15 | 215 | 3 | PS51444 | |
| Domain | Dynein_heavy | 6.18e-04 | 15 | 215 | 3 | PF03028 | |
| Domain | FH2_Formin | 6.18e-04 | 15 | 215 | 3 | IPR015425 | |
| Domain | FH2 | 6.18e-04 | 15 | 215 | 3 | PF02181 | |
| Domain | Dynein_heavy_dom | 6.18e-04 | 15 | 215 | 3 | IPR004273 | |
| Domain | FH2 | 6.18e-04 | 15 | 215 | 3 | SM00498 | |
| Domain | FN3_dom | 7.27e-04 | 209 | 215 | 9 | IPR003961 | |
| Domain | FAM86 | 7.79e-04 | 4 | 215 | 2 | IPR029426 | |
| Domain | Znf_SIAH | 7.79e-04 | 4 | 215 | 2 | IPR013010 | |
| Domain | FAM86 | 7.79e-04 | 4 | 215 | 2 | PF14904 | |
| Domain | LRRNT | 9.48e-04 | 98 | 215 | 6 | IPR000372 | |
| Domain | LRRNT | 9.48e-04 | 98 | 215 | 6 | SM00013 | |
| Domain | LRR_1 | 1.01e-03 | 219 | 215 | 9 | PF00560 | |
| Domain | - | ADCY10 ABCA13 CFTR ABCA9 DDX11 NOD1 NLRC5 DHX35 DNAH9 GNL3 NWD1 RAB25 RNF213 DNAH1 MSH6 NLRP9 DNAH12 RASL11A POLQ | 1.04e-03 | 746 | 215 | 19 | 3.40.50.300 |
| Domain | Kinesin-like_fam | 1.48e-03 | 43 | 215 | 4 | IPR027640 | |
| Domain | NACHT | 2.25e-03 | 23 | 215 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 2.25e-03 | 23 | 215 | 3 | IPR007111 | |
| Domain | Spectrin | 2.25e-03 | 23 | 215 | 3 | PF00435 | |
| Domain | LRR | 2.34e-03 | 201 | 215 | 8 | PS51450 | |
| Domain | TRAF-like | 2.55e-03 | 24 | 215 | 3 | IPR008974 | |
| Domain | fn3 | 2.75e-03 | 162 | 215 | 7 | PF00041 | |
| Pubmed | 6.47e-11 | 6 | 225 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 6.47e-11 | 6 | 225 | 5 | 25930072 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TRIP6 DDX11 TDRD3 MRTFB NFATC3 NOMO2 MCM3AP DIAPH1 RBM15 OBSL1 CEP192 PPP6R1 GSR ZNF451 IQCB1 MACF1 LRIF1 TP53BP1 PCNT NIN | 2.03e-09 | 588 | 225 | 20 | 38580884 |
| Pubmed | PSMD13 UNC45A STK11IP TELO2 COG1 NOMO2 HERC2 BRAT1 WDR62 TBCD STK25 KBTBD6 OBSL1 TTC27 PPP6R1 ARAF NOMO1 MSH6 TMEM131 NOMO3 | 3.38e-09 | 606 | 225 | 20 | 36538041 | |
| Pubmed | FAM86B1 DCHS2 CNKSR1 TRIO LRRC4 RYR3 IQGAP1 SERPINE2 AP2B1 COG1 ADAMTS9 NOMO2 DHX35 HERC2 MERTK DPYSL2 KIF21A KCNAB2 OBSL1 TTC27 SIAH1 DNAAF9 SEC31A ZNF451 MACF1 TMEM131 EIF2AK1 LGI1 PCNT | 5.66e-09 | 1285 | 225 | 29 | 35914814 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TRIO TRIP6 VPS13C SEC24A UNC45A ANKLE2 IQGAP1 MRTFB NFATC3 NOMO2 HERC2 GNL3 WDR62 DPYSL2 FAM184A RELA CEP192 ARAF LIPA NINL TMEM131 PCNT NIN | 9.77e-09 | 853 | 225 | 23 | 28718761 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.73e-08 | 104 | 225 | 9 | 31240132 | |
| Pubmed | CNKSR1 UNC45A ANKLE2 SOX7 MRTFB GORASP1 MCM3AP DIAPH1 HERC2 MERTK TBCD DOCK8 SIAH1 SIAH2 NOMO1 ZNF451 MACF1 NOMO3 | 7.10e-08 | 591 | 225 | 18 | 15231748 | |
| Pubmed | 2.03e-07 | 21 | 225 | 5 | 15014966 | ||
| Pubmed | 2.67e-07 | 3 | 225 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 2.67e-07 | 3 | 225 | 3 | 25576386 | |
| Pubmed | 3.42e-07 | 43 | 225 | 6 | 24172014 | ||
| Pubmed | 4.17e-07 | 24 | 225 | 5 | 32212159 | ||
| Pubmed | PIEZO1 PSMD13 UNC45A ANKLE2 SNX19 NEO1 TELO2 NOMO2 SURF4 HERC2 GNL3 WDR62 FAM184A FLVCR1 OBSL1 KIAA1549 SPG11 CEP192 PPP6R1 ZDHHC17 GSR NOMO1 ZNF451 MACF1 TMEM131 TP53BP1 PCNT NIN | 4.45e-07 | 1487 | 225 | 28 | 33957083 | |
| Pubmed | TENM2 SNX19 RUSC2 STARD9 MCM3AP ZSWIM5 OBSL1 GRB10 CEP192 PPP6R1 ZDHHC17 ZNF451 MACF1 PCNT | 5.02e-07 | 407 | 225 | 14 | 12693553 | |
| Pubmed | SNX19 TASOR2 DIAPH1 GNL3 RBM15 FAM184A OBSL1 FHOD3 EMILIN1 GSR DNAH1 MSH6 DNAH12 MACF1 POLQ | 9.84e-07 | 496 | 225 | 15 | 31343991 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 1.06e-06 | 4 | 225 | 3 | 31833031 | |
| Pubmed | 1.06e-06 | 4 | 225 | 3 | 9267806 | ||
| Pubmed | 1.06e-06 | 4 | 225 | 3 | 36307912 | ||
| Pubmed | TRIO TRIP6 SEC24A PSMD13 ANKLE2 SNX19 TDRD3 TELO2 FBXO33 HERC2 RBM15 FLVCR1 KIAA1549 TTC27 RNF213 RELA CEP192 PPP6R1 PAAF1 MSH6 PCNT NIN | 1.49e-06 | 1049 | 225 | 22 | 27880917 | |
| Pubmed | GHDC SEC24A SURF4 BRAT1 GNL3 TBCD GRB10 RELA PAAF1 KIF20A MSH6 LIPA | 1.60e-06 | 325 | 225 | 12 | 36168628 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 3.69e-06 | 139 | 225 | 8 | 25476789 | |
| Pubmed | KCTD9 TRIO TENM2 IQGAP1 TDRD3 AP2B1 NFATC3 DIAPH1 HERC2 DPYSL2 KIF21A KCNAB2 NSD1 PPP6R1 SEC31A MACF1 TP53BP1 LRRC15 LGI1 PCNT | 5.27e-06 | 963 | 225 | 20 | 28671696 | |
| Pubmed | FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and cell migration. | 7.59e-06 | 42 | 225 | 5 | 29348145 | |
| Pubmed | CDH23 TENM2 RUSC2 SERPINA1 GNL3 WDR62 KIF21A SIAH2 PPP6R1 RGS14 | 7.60e-06 | 257 | 225 | 10 | 30945288 | |
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 8.64e-06 | 156 | 225 | 8 | 30409884 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | KCTD9 GHDC UNC45A ANKLE2 IQGAP1 SLIT2 TELO2 COG1 SURF4 BRAT1 TBCD SGSH FLVCR1 OBSL1 TTC27 PPP6R1 SEC31A ZDHHC17 NOMO3 | 1.37e-05 | 942 | 225 | 19 | 31073040 |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.46e-05 | 8 | 225 | 3 | 15257293 | |
| Pubmed | BRAF AP2B1 MCM3AP HERC2 RELA SEC31A ZDHHC17 ARAF SLC9A1 ZNF451 FHOD1 MACF1 ARHGAP33 | 1.93e-05 | 486 | 225 | 13 | 20936779 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 2.18e-05 | 9 | 225 | 3 | 36261522 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 TRIP6 PSMD13 SPATA31A6 RYR3 SERPINA1 RBM15 NWD1 SPG11 ARAF DNAH12 KIAA0825 MUC4 | 2.44e-05 | 497 | 225 | 13 | 36774506 |
| Pubmed | Coordination of endothelial cell positioning and fate specification by the epicardium. | 3.10e-05 | 10 | 225 | 3 | 34230480 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRIO TMEM8B PIEZO1 ZNF236 STK11IP TDRD3 MCM3AP NLRC5 HERC2 BRAT1 TBCD NSD1 GRB10 SIAH2 CEP192 PPP6R1 NINL ARHGAP33 PCNT PPP1R16A | 3.78e-05 | 1105 | 225 | 20 | 35748872 |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 24809345 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 32005666 | ||
| Pubmed | Isolation and characterisation of murine homologues of the Drosophila seven in absentia gene (sina). | 4.17e-05 | 2 | 225 | 2 | 8404535 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 30717343 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 18209474 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 16899216 | ||
| Pubmed | B-Raf associates with and activates the NHE1 isoform of the Na+/H+ exchanger. | 4.17e-05 | 2 | 225 | 2 | 21345796 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 33188786 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 23374272 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 14645526 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 34201899 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 11689484 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 11689483 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 9760292 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 23264583 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 24067439 | ||
| Pubmed | Distinct roles of Kif6 and Kif9 in mammalian ciliary trafficking and motility. | 4.17e-05 | 2 | 225 | 2 | 39158699 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 15966898 | ||
| Pubmed | Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung disease. | 4.17e-05 | 2 | 225 | 2 | 12689922 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 30504064 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 25794445 | ||
| Pubmed | Characterization of human homologs of the Drosophila seven in absentia (sina) gene. | 4.17e-05 | 2 | 225 | 2 | 9403064 | |
| Pubmed | Bethlem myopathy: a series of 16 patients and description of seven new associated mutations. | 4.17e-05 | 2 | 225 | 2 | 30706156 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 22814862 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 18850011 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 17563371 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 33946490 | ||
| Pubmed | Identification and characterization of human FHOD3 gene in silico. | 4.17e-05 | 2 | 225 | 2 | 15010865 | |
| Pubmed | KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adults. | 4.17e-05 | 2 | 225 | 2 | 22591444 | |
| Pubmed | Loss of mDia1 and Fhod1 impacts platelet formation but not platelet function. | 4.17e-05 | 2 | 225 | 2 | 32981398 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 24529209 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 26654769 | ||
| Pubmed | BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults. | 4.17e-05 | 2 | 225 | 2 | 21696415 | |
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 28270177 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 18974108 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 32389683 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 16799633 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 38582447 | ||
| Pubmed | 4.17e-05 | 2 | 225 | 2 | 26945035 | ||
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 4.24e-05 | 11 | 225 | 3 | 32820719 | |
| Pubmed | TRIP6 INPP5K SLIT2 TELO2 MCM3AP DIAPH1 GNL3 WDR62 ARMC6 OBSL1 KIAA1549 TTC27 RNF213 PPP6R1 ARAF KIF20A MSH6 MACF1 ARHGAP33 NIN | 4.33e-05 | 1116 | 225 | 20 | 31753913 | |
| Pubmed | Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. | 4.68e-05 | 31 | 225 | 4 | 25838543 | |
| Pubmed | SERPINA1 SERPINA4 NEO1 FCGBP C5 MERTK COL6A3 SERPINA10 SERPINA5 | 4.95e-05 | 257 | 225 | 9 | 16335952 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A TRIO TRIP6 SEC24A UNC45A RUSC2 BRAF NFATC3 STARD9 FOXO4 WDR62 RBM15 GRB10 CEP192 ARAF IQCB1 MACF1 | 5.12e-05 | 861 | 225 | 17 | 36931259 |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | IQGAP1 AP2B1 SURF4 STOML1 DNAH9 PLS1 GNL3 DPYSL2 DOCK8 RGS14 | 6.90e-05 | 333 | 225 | 10 | 32665550 |
| Pubmed | 7.02e-05 | 209 | 225 | 8 | 26389662 | ||
| Pubmed | Sequence and expression of murine type I hair keratins mHa2 and mHa3. | 9.23e-05 | 14 | 225 | 3 | 7514534 | |
| Pubmed | Expression of multiple formins in adult tissues and during developmental stages of mouse brain. | 9.23e-05 | 14 | 225 | 3 | 26272686 | |
| Pubmed | All kinesin superfamily protein, KIF, genes in mouse and human. | 9.53e-05 | 37 | 225 | 4 | 11416179 | |
| Pubmed | TRIO VPS13C TDRD3 NEO1 NOMO2 DIAPH1 GNL3 WDR62 DPYSL2 RNF213 SPG11 ZNF451 IQCB1 TMEM131 N4BP1 | 9.62e-05 | 733 | 225 | 15 | 34672954 | |
| Pubmed | 1.03e-04 | 283 | 225 | 9 | 21903422 | ||
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | TRIP6 CLEC7A TASOR2 SERPINA1 KIF9 NOD1 GORASP1 WDR62 STK25 DOCK8 SIAH1 EMILIN1 ARAF CTNS LGI1 | 1.10e-04 | 742 | 225 | 15 | 26871637 |
| Pubmed | 1.15e-04 | 15 | 225 | 3 | 26395479 | ||
| Pubmed | CNKSR1 ANKLE2 IQGAP1 BRAF BRAT1 RBM15 DPYSL2 GRB10 ARAF MSH6 TMEM131 TP53BP1 | 1.19e-04 | 503 | 225 | 12 | 16964243 | |
| Pubmed | RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. | 1.24e-04 | 3 | 225 | 2 | 20130576 | |
| Pubmed | Genetic and biochemical markers of obstructive lung disease in the general population. | 1.24e-04 | 3 | 225 | 2 | 20298391 | |
| Pubmed | Amino acid sequence of the triple-helical domain of human collagen type VI. | 1.24e-04 | 3 | 225 | 2 | 3198591 | |
| Pubmed | 1.24e-04 | 3 | 225 | 2 | 8489506 | ||
| Pubmed | Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. | 1.24e-04 | 3 | 225 | 2 | 18366090 | |
| Pubmed | Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling. | 1.24e-04 | 3 | 225 | 2 | 23352452 | |
| Pubmed | Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. | 1.24e-04 | 3 | 225 | 2 | 12810624 | |
| Pubmed | 1.24e-04 | 3 | 225 | 2 | 16141002 | ||
| Pubmed | 1.24e-04 | 3 | 225 | 2 | 14645235 | ||
| Pubmed | Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis. | 1.24e-04 | 3 | 225 | 2 | 10704835 | |
| Pubmed | 1.24e-04 | 3 | 225 | 2 | 21903858 | ||
| Pubmed | 1.24e-04 | 3 | 225 | 2 | 20301676 | ||
| Pubmed | 1.24e-04 | 3 | 225 | 2 | 34933181 | ||
| Interaction | GPR55 interactions | 6.58e-06 | 67 | 212 | 7 | int:GPR55 | |
| Interaction | FBXO2 interactions | CDHR2 PIEZO1 CBLIF SLIT2 SERPINA1 SERPINE2 MERTK COL6A1 SGSH LAMC2 NOMO1 LIPA IQCB1 TMEM131 SERPINA5 NOMO3 | 7.82e-06 | 411 | 212 | 16 | int:FBXO2 |
| Interaction | CLEC16A interactions | PSMD13 UNC45A STK11IP TELO2 COG1 NOMO2 HERC2 BRAT1 WDR62 TBCD STK25 KBTBD6 OBSL1 TTC27 PPP6R1 ARAF NOMO1 MSH6 TMEM131 NOMO3 | 1.17e-05 | 629 | 212 | 20 | int:CLEC16A |
| Cytoband | 14q32.13 | 7.41e-05 | 17 | 224 | 3 | 14q32.13 | |
| GeneFamily | Serpin peptidase inhibitors | 4.19e-07 | 37 | 143 | 6 | 739 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.42e-06 | 161 | 143 | 9 | 593 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 3.05e-05 | 46 | 143 | 5 | 622 | |
| GeneFamily | Dyneins, axonemal | 3.04e-04 | 17 | 143 | 3 | 536 | |
| GeneFamily | Cadherin related | 3.04e-04 | 17 | 143 | 3 | 24 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 6.12e-04 | 5 | 143 | 2 | 1157 | |
| GeneFamily | Immunoglobulin like domain containing | 8.73e-04 | 193 | 143 | 7 | 594 | |
| GeneFamily | NLR family | 9.81e-04 | 25 | 143 | 3 | 666 | |
| GeneFamily | Fibronectin type III domain containing | 1.72e-03 | 160 | 143 | 6 | 555 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.16e-03 | 9 | 143 | 2 | 1234 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.16e-03 | 9 | 143 | 2 | 1230 | |
| GeneFamily | WD repeat domain containing | 4.88e-03 | 262 | 143 | 7 | 362 | |
| GeneFamily | ATP binding cassette subfamily A | 5.31e-03 | 14 | 143 | 2 | 805 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VPS13C CLEC7A ANKLE2 ABCA9 IQGAP1 DIAPH1 DOCK8 NSD1 MACF1 NIN | 3.33e-08 | 185 | 222 | 10 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | DENND4A VPS13C TASOR2 BRAF RNF213 ZNF407 PARP14 MACF1 TMEM131 TP53BP1 | 3.87e-08 | 188 | 222 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | ABCA13 DNAH9 NWD1 RAB25 PLEKHG7 C1orf87 TMC4 DNAH12 SPAG17 MUC4 | 6.61e-08 | 199 | 222 | 10 | 74087b4b5e567310fc4ac58fb267ff651a180680 |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | ABCA13 DNAH9 NWD1 RAB25 PLEKHG7 C1orf87 TMC4 DNAH12 SPAG17 MUC4 | 6.61e-08 | 199 | 222 | 10 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | VIT ABCA9 SLIT2 SERPINE2 SCN7A NOVA1 COL6A1 COL6A3 ADAMTSL3 EMILIN1 | 6.93e-08 | 200 | 222 | 10 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f |
| ToppCell | Biopsy_IPF-Mesenchymal-Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | VIT ABCA9 SLIT2 SCN7A COL6A1 COL6A3 ADAMTSL3 EMILIN1 SEMA3D SERPINA5 | 6.93e-08 | 200 | 222 | 10 | d8637f1e62d3fb9476dc51e1b1dc2f4b14b5fcd8 |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | VIT ABCA9 SLIT2 SERPINE2 SCN7A NOVA1 COL6A1 COL6A3 ADAMTSL3 EMILIN1 | 6.93e-08 | 200 | 222 | 10 | 1c10597edd532bf172ca09870a937d35e2585081 |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | VIT ABCA9 SLIT2 SERPINE2 SCN7A NOVA1 COL6A1 COL6A3 ADAMTSL3 EMILIN1 | 6.93e-08 | 200 | 222 | 10 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | ABCA13 CNTN5 DNAH9 FAM184A C1orf87 KIF21A LAMC2 DNAH12 SPAG17 | 9.38e-08 | 156 | 222 | 9 | 10d191e29b16cae8238e8df6c0ff38882253f34e |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.37e-07 | 163 | 222 | 9 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-07 | 182 | 222 | 9 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | VIT ABCA9 SERPINE2 ADAMTS9 SCN7A NOVA1 COL6A1 COL6A3 ADAMTSL3 | 3.48e-07 | 182 | 222 | 9 | fbd5e332df73bf7141c822fa67b76367dc962017 |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.99e-07 | 185 | 222 | 9 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.57e-07 | 188 | 222 | 9 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.57e-07 | 188 | 222 | 9 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 4.57e-07 | 188 | 222 | 9 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 5.22e-07 | 191 | 222 | 9 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 5.22e-07 | 191 | 222 | 9 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.22e-07 | 191 | 222 | 9 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 5.22e-07 | 191 | 222 | 9 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | ABCA9 SLIT2 SERPINE2 NOVA1 COL6A1 COL6A3 ADAMTSL3 EMILIN1 SEMA3D | 5.45e-07 | 192 | 222 | 9 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | ZCCHC24 VIT ABCA9 SLIT2 SERPINE2 NOVA1 COL6A1 COL6A3 ADAMTSL3 | 5.45e-07 | 192 | 222 | 9 | d21f0f577156f17c899b08871046a26b88aea011 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | ABCA9 SLIT2 SERPINE2 SCN7A NOVA1 COL6A1 COL6A3 ADAMTSL3 SEMA3D | 5.70e-07 | 193 | 222 | 9 | 9ab47b360bee1d4f1092c2269e58acebe9584021 |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 5.95e-07 | 194 | 222 | 9 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 5.95e-07 | 194 | 222 | 9 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.21e-07 | 195 | 222 | 9 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 6.76e-07 | 197 | 222 | 9 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | ABCA9 SLIT2 SERPINE2 SCN7A NOVA1 COL6A1 COL6A3 SH3TC2 EMILIN1 | 7.05e-07 | 198 | 222 | 9 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.05e-07 | 198 | 222 | 9 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.36e-07 | 199 | 222 | 9 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 7.36e-07 | 199 | 222 | 9 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.36e-07 | 199 | 222 | 9 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 7.36e-07 | 199 | 222 | 9 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | VIT ABCA9 SLIT2 SERPINE2 NOVA1 COL6A1 COL6A3 SH3TC2 ADAMTSL3 | 7.36e-07 | 199 | 222 | 9 | 993fa050a095017135a6e723c77cd38b9d782e58 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.36e-07 | 199 | 222 | 9 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.36e-07 | 199 | 222 | 9 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 7.36e-07 | 199 | 222 | 9 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.36e-07 | 199 | 222 | 9 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.67e-07 | 200 | 222 | 9 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Differentiating_Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 7.67e-07 | 200 | 222 | 9 | f7b4581d958afbd68f9045af619aaca0ab463439 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.67e-07 | 200 | 222 | 9 | 2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 7.67e-07 | 200 | 222 | 9 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CPAMD8 ABCA9 SLIT2 STARD9 SCN7A NOVA1 COL6A1 COL6A3 ADAMTSL3 | 7.67e-07 | 200 | 222 | 9 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.67e-07 | 200 | 222 | 9 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.67e-07 | 200 | 222 | 9 | e1da1b15d2ca06796ee1ab7cef586ae0b4dc0a0a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA9 SLIT2 SERPINE2 SCN7A NOVA1 COL6A1 COL6A3 ADAMTSL3 SEMA3D | 7.67e-07 | 200 | 222 | 9 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-06 | 164 | 222 | 8 | 9e16e52f5a634585f26021bcce9b5d5992ff6db0 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.75e-06 | 164 | 222 | 8 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-06 | 166 | 222 | 8 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-06 | 166 | 222 | 8 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-06 | 166 | 222 | 8 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 168 | 222 | 8 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 168 | 222 | 8 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.19e-06 | 169 | 222 | 8 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.19e-06 | 169 | 222 | 8 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.19e-06 | 169 | 222 | 8 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-06 | 173 | 222 | 8 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-06 | 178 | 222 | 8 | ea10117026021c959ffc871fc377cdb3e161d264 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-06 | 182 | 222 | 8 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.95e-06 | 183 | 222 | 8 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-06 | 184 | 222 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-06 | 184 | 222 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-06 | 184 | 222 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 4.28e-06 | 185 | 222 | 8 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.28e-06 | 185 | 222 | 8 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-06 | 186 | 222 | 8 | aa88d9573a237b2b8e6025fee31f69fbce824497 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-06 | 186 | 222 | 8 | ecc5acd111a6ee50d59544d1bdd7ed94e2812aae | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 4.45e-06 | 186 | 222 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.45e-06 | 186 | 222 | 8 | 26458ff8cad5577de4306cffa0ca69eb26940e0d | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.45e-06 | 186 | 222 | 8 | a71397efc68d2916ddc373d92cfd07be58033e1c | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.63e-06 | 187 | 222 | 8 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 4.63e-06 | 187 | 222 | 8 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 5.01e-06 | 189 | 222 | 8 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 5.01e-06 | 189 | 222 | 8 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.01e-06 | 189 | 222 | 8 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.21e-06 | 190 | 222 | 8 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.41e-06 | 191 | 222 | 8 | 509230f50568e5a8ecf08edc4d58f9e2aa96efe9 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.41e-06 | 191 | 222 | 8 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.41e-06 | 191 | 222 | 8 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.41e-06 | 191 | 222 | 8 | 0b3dbbc35d9970d3c749aef16dda59886b960e3d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.41e-06 | 191 | 222 | 8 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.41e-06 | 191 | 222 | 8 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.41e-06 | 191 | 222 | 8 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.41e-06 | 191 | 222 | 8 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.41e-06 | 191 | 222 | 8 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 5.62e-06 | 192 | 222 | 8 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.62e-06 | 192 | 222 | 8 | 03acd4a26b986e34eee608747347791122f1aa52 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.62e-06 | 192 | 222 | 8 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.62e-06 | 192 | 222 | 8 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.62e-06 | 192 | 222 | 8 | 31c6046589e2fbb0486fd044c5b128099d37872f | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 5.62e-06 | 192 | 222 | 8 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.84e-06 | 193 | 222 | 8 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 193 | 222 | 8 | 76f0f8569255d6cdf1e3b8e954cae72e71f87157 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.84e-06 | 193 | 222 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 5.84e-06 | 193 | 222 | 8 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | 3'-Distal_airway|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-06 | 194 | 222 | 8 | e9ff4398e880d13894e52c0ba9cf19a7662c248b | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.07e-06 | 194 | 222 | 8 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.07e-06 | 194 | 222 | 8 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.07e-06 | 194 | 222 | 8 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.30e-06 | 195 | 222 | 8 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| Disease | kallistatin measurement | 1.81e-07 | 8 | 213 | 4 | EFO_0008196 | |
| Disease | alpha-1-antitrypsin measurement | 3.02e-05 | 9 | 213 | 3 | EFO_0008327 | |
| Disease | alcohol-induced mental disorder (biomarker_via_orthology) | 5.19e-05 | 2 | 213 | 2 | DOID:251 (biomarker_via_orthology) | |
| Disease | Ullrich congenital muscular dystrophy (implicated_via_orthology) | 5.19e-05 | 2 | 213 | 2 | DOID:0050558 (implicated_via_orthology) | |
| Disease | neutrophil percentage of leukocytes | DENND4A SPTA1 CDH23 PSMD13 IQGAP1 NLRC5 MERTK FRAT1 DOCK8 SEC31A LIPA CMIP TMEM87B TMEM131 | 1.53e-04 | 610 | 213 | 14 | EFO_0007990 |
| Disease | protein Z-dependent protease inhibitor measurement | 2.79e-04 | 18 | 213 | 3 | EFO_0021849 | |
| Disease | familial non-medullary thyroid cancer | 3.08e-04 | 4 | 213 | 2 | C4733333 | |
| Disease | Ullrich congenital muscular dystrophy | 3.08e-04 | 4 | 213 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 3.08e-04 | 4 | 213 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 3.08e-04 | 4 | 213 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 3.08e-04 | 4 | 213 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 3.08e-04 | 4 | 213 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 3.08e-04 | 4 | 213 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | cortical surface area measurement | DCHS2 CPAMD8 FBXL13 NBEAL1 TMEM8B TENM2 SLIT2 SERPINA1 NEO1 KCNA5 ADAMTS9 PLS1 NOVA1 DPYSL2 KIF6 DNAAF9 ADAMTSL3 SIAH3 SEMA3D KIAA0825 MACF1 SPAG17 | 3.14e-04 | 1345 | 213 | 22 | EFO_0010736 |
| Disease | aspartate aminotransferase, cytoplasmic measurement | 5.11e-04 | 5 | 213 | 2 | EFO_0008031 | |
| Disease | kallikrein-13 measurement | 5.11e-04 | 5 | 213 | 2 | EFO_0020512 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 7.23e-04 | 56 | 213 | 4 | EFO_0022251 | |
| Disease | glucagon measurement, glucose tolerance test | 7.63e-04 | 6 | 213 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 7.63e-04 | 6 | 213 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | CIART PIEZO1 SPTA1 CDH23 ITGAD LIN9 IQGAP1 SOX7 NEO1 AP2B1 COG1 CNTN5 PLS1 GNL3 DOCK8 ZNF407 SIAH2 LIPA EIF2AK1 MUC4 ENO3 | 7.97e-04 | 1347 | 213 | 21 | EFO_0005192 |
| Disease | alpha fetoprotein measurement | 8.08e-04 | 100 | 213 | 5 | EFO_0010583 | |
| Disease | Glycosuria | 1.06e-03 | 7 | 213 | 2 | HP_0003076 | |
| Disease | Pilomyxoid astrocytoma | 1.06e-03 | 7 | 213 | 2 | C1519086 | |
| Disease | Child Development Disorders, Specific | 1.18e-03 | 29 | 213 | 3 | C0085997 | |
| Disease | Child Development Deviations | 1.18e-03 | 29 | 213 | 3 | C0085996 | |
| Disease | Cholestasis | 1.24e-03 | 110 | 213 | 5 | C0008370 | |
| Disease | cortical thickness | CPAMD8 FBXL13 NBEAL1 NUP210L VIT TENM2 SLIT2 SERPINA1 NEO1 KCNA5 ADAMTS9 DPYSL2 KIF6 DNAAF9 ADAMTSL3 KIAA0825 MACF1 TMEM131 | 1.26e-03 | 1113 | 213 | 18 | EFO_0004840 |
| Disease | Developmental Disabilities | 1.30e-03 | 30 | 213 | 3 | C0008073 | |
| Disease | pulmonary hypertension (is_implicated_in) | 1.30e-03 | 30 | 213 | 3 | DOID:6432 (is_implicated_in) | |
| Disease | pantothenate measurement | 1.41e-03 | 8 | 213 | 2 | EFO_0021034 | |
| Disease | response to vitamin | 1.41e-03 | 8 | 213 | 2 | GO_0033273 | |
| Disease | bilirubin measurement | ZCCHC24 DCHS2 PIEZO1 SPTA1 SERPINA1 CNTN5 ARMC6 TTC27 ZNF407 OR10Z1 | 1.49e-03 | 442 | 213 | 10 | EFO_0004570 |
| Disease | Drug habituation | 1.51e-03 | 115 | 213 | 5 | C0013170 | |
| Disease | Drug abuse | 1.51e-03 | 115 | 213 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.51e-03 | 115 | 213 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 1.51e-03 | 115 | 213 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 1.51e-03 | 115 | 213 | 5 | C0013222 | |
| Disease | Drug Dependence | 1.51e-03 | 115 | 213 | 5 | C1510472 | |
| Disease | Substance Dependence | 1.51e-03 | 115 | 213 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 1.51e-03 | 115 | 213 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.51e-03 | 115 | 213 | 5 | C0029231 | |
| Disease | Substance abuse problem | 1.57e-03 | 116 | 213 | 5 | C0740858 | |
| Disease | Colorectal Carcinoma | CPAMD8 ABCA13 CFTR LRRC4 ABCA9 BRAF MCM3AP DPYSL2 ADAMTSL3 LGR5 MSH6 RASL11A SPAG17 | 1.88e-03 | 702 | 213 | 13 | C0009402 |
| Disease | Reactive hypoglycemia | 2.25e-03 | 10 | 213 | 2 | C0271710 | |
| Disease | Fasting Hypoglycemia | 2.25e-03 | 10 | 213 | 2 | C0271708 | |
| Disease | otitis media (is_marker_for) | 2.25e-03 | 10 | 213 | 2 | DOID:10754 (is_marker_for) | |
| Disease | brain measurement, neuroimaging measurement | DCHS2 SLIT2 SERPINA1 NEO1 KCNA5 ADAMTS9 DPYSL2 KIF6 GRB10 LAMC2 MACF1 | 2.31e-03 | 550 | 213 | 11 | EFO_0004346, EFO_0004464 |
| Disease | Malignant neoplasm of brain | 2.60e-03 | 38 | 213 | 3 | C0153633 | |
| Disease | UDP-glucuronic acid decarboxylase 1 measurement | 2.73e-03 | 11 | 213 | 2 | EFO_0803221 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 2.73e-03 | 11 | 213 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Hypoglycemia | 2.73e-03 | 11 | 213 | 2 | C0020615 | |
| Disease | prostatic hypertrophy (is_marker_for) | 2.73e-03 | 11 | 213 | 2 | DOID:11132 (is_marker_for) | |
| Disease | C-C motif chemokine 15 measurement | 2.73e-03 | 11 | 213 | 2 | EFO_0008043 | |
| Disease | Degenerative Diseases, Central Nervous System | 2.80e-03 | 39 | 213 | 3 | C0270715 | |
| Disease | Neurodegenerative Disorders | 2.80e-03 | 39 | 213 | 3 | C0524851 | |
| Disease | Degenerative Diseases, Spinal Cord | 2.80e-03 | 39 | 213 | 3 | C0751733 | |
| Disease | Brain Neoplasms | 2.80e-03 | 39 | 213 | 3 | C0006118 | |
| Disease | Varicose veins | 2.86e-03 | 193 | 213 | 6 | HP_0002619 | |
| Disease | C-reactive protein measurement | DCHS2 NUP210L VPS13C VIT SLC30A3 SOX7 SERPINA1 NEO1 MERTK KLF15 SPG11 CEP192 LIPA CMIP MACF1 SERPINA10 ARHGAP33 TP53BP1 | 3.00e-03 | 1206 | 213 | 18 | EFO_0004458 |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 3.26e-03 | 12 | 213 | 2 | EFO_0801493 | |
| Disease | Profound Mental Retardation | 3.44e-03 | 139 | 213 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 3.44e-03 | 139 | 213 | 5 | C0025363 | |
| Disease | Mental deficiency | 3.44e-03 | 139 | 213 | 5 | C0917816 | |
| Disease | diffuse plaque measurement | DCHS2 CNKSR1 ABCA13 CNTN5 ROBO3 STK25 COL6A3 DOCK8 SIAH3 MSH6 CMIP MACF1 EIF2AK1 | 3.62e-03 | 758 | 213 | 13 | EFO_0010699 |
| Disease | fibroblast growth factor 23 measurement | 3.70e-03 | 43 | 213 | 3 | EFO_0009381 | |
| Disease | Anemia, Hemolytic, Acquired | 3.84e-03 | 13 | 213 | 2 | C0002879 | |
| Disease | Anemia, Hemolytic | 3.84e-03 | 13 | 213 | 2 | C0002878 | |
| Disease | Anemia, Microangiopathic | 3.84e-03 | 13 | 213 | 2 | C0002889 | |
| Disease | Microangiopathic hemolytic anemia | 3.84e-03 | 13 | 213 | 2 | C0221021 | |
| Disease | esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement | 3.84e-03 | 13 | 213 | 2 | EFO_0000280, EFO_0000478, EFO_0008343 | |
| Disease | HbA1c measurement | CPAMD8 PIEZO1 SPTA1 PSMD13 ITGAD CNTN5 TBCD OR10T2 OR10Z1 HINFP CMIP MACF1 | 3.86e-03 | 675 | 213 | 12 | EFO_0004541 |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 3.90e-03 | 274 | 213 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | high grade glioma (implicated_via_orthology) | 3.95e-03 | 44 | 213 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 4.14e-03 | 277 | 213 | 7 | C0009404 | |
| Disease | adiponectin measurement | 4.24e-03 | 146 | 213 | 5 | EFO_0004502 | |
| Disease | Malformations of Cortical Development | 4.46e-03 | 14 | 213 | 2 | C1955869 | |
| Disease | femoral neck bone geometry | 4.46e-03 | 14 | 213 | 2 | EFO_0004511 | |
| Disease | Cortical Dysplasia | 4.46e-03 | 14 | 213 | 2 | C0431380 | |
| Disease | selective IgA deficiency disease | 4.48e-03 | 46 | 213 | 3 | EFO_1001929 | |
| Disease | osteoarthritis, hip | 4.49e-03 | 92 | 213 | 4 | EFO_1000786 | |
| Disease | hemolysis | 4.76e-03 | 47 | 213 | 3 | EFO_0009473 | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 4.76e-03 | 47 | 213 | 3 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | Replication Error Phenotype | 5.12e-03 | 15 | 213 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 5.12e-03 | 15 | 213 | 2 | C0920269 | |
| Disease | brain edema (biomarker_via_orthology) | 5.12e-03 | 15 | 213 | 2 | DOID:4724 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | INPP5K SERPINE2 KCNA5 BRAF NLRC5 HERC2 DNAH9 KIF6 ZSWIM5 C1orf87 RELA ARAF MSH6 NLRP9 MACF1 TP53BP1 | 5.14e-03 | 1074 | 213 | 16 | C0006142 |
| Disease | Tinnitus, wellbeing measurement | 5.23e-03 | 96 | 213 | 4 | EFO_0007869, HP_0000360 | |
| Disease | prostate carcinoma | TRIO ZNF236 TASOR2 SERPINA1 COL6A3 RBM15 TMEM204 NSD1 GRB10 RNF213 SIAH2 DNAH12 LRIF1 EPHA10 | 5.53e-03 | 891 | 213 | 14 | EFO_0001663 |
| Disease | neutrophil count | CPAMD8 DENND4A NUP210L CDH23 LIN9 TELO2 NLRC5 SEMA4A FRAT1 DOCK8 FLVCR1 NSD1 TMC4 FRAT2 SLC9A1 LIPA CMIP TMEM87B PCNT | 5.59e-03 | 1382 | 213 | 19 | EFO_0004833 |
| Disease | urate measurement, bone density | TENM2 SNX19 KCNA5 DIAPH1 DHX35 DNAH9 KIF6 SIAH1 SEC31A GRIN2C DNAH1 | 5.59e-03 | 619 | 213 | 11 | EFO_0003923, EFO_0004531 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 5.65e-03 | 222 | 213 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 5.66e-03 | 50 | 213 | 3 | EFO_0022247 | |
| Disease | Barrett Epithelium | 5.82e-03 | 16 | 213 | 2 | C1258085 | |
| Disease | Barrett Esophagus | 5.82e-03 | 16 | 213 | 2 | C0004763 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 6.02e-03 | 225 | 213 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | Moyamoya Disease | 6.57e-03 | 17 | 213 | 2 | C0026654 | |
| Disease | alcoholic liver cirrhosis | 6.57e-03 | 17 | 213 | 2 | EFO_1000802 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 6.69e-03 | 103 | 213 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | epilepsy (implicated_via_orthology) | 6.72e-03 | 163 | 213 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Retinitis Pigmentosa | 6.92e-03 | 104 | 213 | 4 | C0035334 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVGSGSEIQFLSEAQ | 341 | Q8NBZ7 | |
| EQQLLESLGNGTDFS | 96 | P15056 | |
| QRAALDFLGTLSQGT | 426 | Q6PJG6 | |
| LAQALLEQGGRLSSF | 106 | Q86XL3 | |
| VSSGLNDLFELSTGI | 686 | P63010 | |
| EGGNAILENISFSIS | 1221 | P13569 | |
| GNLFSLELGDISAVL | 76 | P51589 | |
| SNTEEIANGLLFLNS | 206 | Q86TB3 | |
| LLDVISNGLLGIFNS | 986 | Q8IUA7 | |
| DSQLQLTTGNGLFLS | 131 | P01009 | |
| VEELLQSSLSLGGQE | 176 | Q8NEB7 | |
| LATAGDQGLLLQSLN | 146 | Q6NXE6 | |
| SLGITSDGFFQLEEL | 216 | P00390 | |
| LSSGSFGNLENLSLA | 656 | Q8IY22 | |
| FSSGGDNLDLTRVLL | 4271 | Q86UQ4 | |
| GLFLNTALRLSETQG | 1531 | Q96PN6 | |
| QTFGAEGLASLLDIL | 181 | O60610 | |
| ESFSNLLEITLLVGN | 971 | O60610 | |
| QLLGAQSGLFDINSS | 2001 | Q9H251 | |
| LGSAEGLIASLQDSQ | 566 | Q8NB25 | |
| LLTGANSSRFLDGNI | 101 | Q8N0U7 | |
| NESFVILTGLEGNTL | 931 | O94779 | |
| FDIIDLSAGGQLTTD | 1206 | P46940 | |
| FGTENNLIITGSLDA | 1136 | Q149M9 | |
| GLDTSALSVQGNFDL | 1536 | Q7Z401 | |
| SGLGLLLNEALVNTS | 1186 | Q6ZS30 | |
| NNGLLFLETSALDST | 146 | P57735 | |
| LQGDLQVASSLLVEG | 806 | Q96T37 | |
| ENLGLNFISGDISDT | 531 | Q96L73 | |
| SLSGGLFRSNLLTQD | 896 | P69849 | |
| GATLGTLFQIDSAQD | 91 | Q96TA0 | |
| GFLNGSEVSELLRNL | 1121 | Q9HCM3 | |
| ISEGGSATFQLELSQ | 1551 | O75147 | |
| NTGILLISGLQSEDE | 96 | A0A075B6J1 | |
| FLLVGAQDGNSSFLL | 4706 | Q99102 | |
| LSLGTVLLSANQGFS | 186 | P57723 | |
| SLSGGLFRSNLLTQD | 896 | Q5JPE7 | |
| IGFGNSVLQSSLTLN | 151 | O76000 | |
| VLLNGLSLEADITGN | 201 | P0C5J1 | |
| QGLNFSGADLSRLDL | 221 | Q7L273 | |
| GLFTGQIDAVDTLNA | 236 | Q5TKA1 | |
| ALSFSLLVGGQELEG | 146 | Q13477 | |
| FEDGNTVELLTGASL | 1026 | Q8IV33 | |
| GEANVTGSQLLSSIL | 656 | Q5T3J3 | |
| NAGLLLISGLQSEDE | 96 | A0A0G2JS06 | |
| QLLESSEGLAQGSTL | 876 | Q12866 | |
| AALVQGETGLISLSQ | 461 | P61550 | |
| LASLRQFLESGVLGS | 476 | Q16538 | |
| FLNSLLSCGDLQVTG | 316 | Q16555 | |
| QSLTGNSILAQFAGE | 1241 | O95714 | |
| NVLSVTGANLSLGSF | 1651 | Q5HYC2 | |
| SDAGGIQTLSLFNSL | 1401 | O60318 | |
| SSLGLTGLQSLLQGF | 41 | Q9UK85 | |
| SLFGDISVLQQQGSL | 206 | Q7Z6M2 | |
| NVLLNGLSLEADITG | 166 | Q8N7N1 | |
| GQDLNEGNSTLTLAL | 481 | Q14651 | |
| NEGLELLDGLNLTSS | 301 | P98177 | |
| AFLSTSEGLILQLVG | 156 | Q96AB3 | |
| IFLGLSDSQELQTFL | 6 | Q8NH21 | |
| QDLGEASLQATLLGL | 121 | Q8N2G8 | |
| GSLSASLENQLEAFL | 961 | Q9ULH7 | |
| SLSGGLFRSNLLTQD | 896 | Q15155 | |
| QTGASGSTDQILLEI | 2806 | Q6ZR08 | |
| LVGFSNESLGSLNSL | 166 | Q9Y239 | |
| QATTEEEALNLLFLG | 191 | Q6ZMV9 | |
| VGAFNGLASLNTLEL | 116 | Q9HBW1 | |
| LVGNVANSDGLIASL | 66 | Q9BY08 | |
| SLEELGSNTGIQVFN | 26 | P07093 | |
| SLSFLEQAIIALGDQ | 271 | Q9HAQ2 | |
| SEQQERAFTLGLAGL | 191 | Q9UNM6 | |
| SQRLGFLAEALTLGQ | 686 | Q5JZY3 | |
| IFLGLSDSQGLQTFL | 6 | Q8NGA8 | |
| IQGFLAALTTANQDG | 566 | Q96FC9 | |
| FLNGTNGSTEGTLLE | 746 | P52701 | |
| LLLLIGGFQDSEQET | 3156 | O95613 | |
| GFLDVSGISLLDNSN | 306 | Q9BQQ3 | |
| GVLGELNQSQLSDLS | 91 | A8MVS5 | |
| GVSSVLLGASNADQL | 316 | Q13303 | |
| LGALQSLNLSENGLS | 1031 | Q86WI3 | |
| SQVDLSANLLGDSGL | 1246 | Q86WI3 | |
| TGNFVDLISGQRLTL | 2586 | Q9UPN3 | |
| LSLLSVRDGFIASQG | 326 | Q9BRP4 | |
| TQFILVGFSSLGELQ | 11 | Q8NGX3 | |
| GFSSSGELQLLLFAL | 16 | Q8NGY1 | |
| QTQVTEFLLLGLSDG | 6 | Q9H210 | |
| VIQVFATDLDSGLNG | 2261 | Q6V1P9 | |
| GLQTLTVGSSLELNV | 786 | Q13349 | |
| GNSGIILLINTDSRF | 41 | Q8NH90 | |
| ILLVENISGLSNDDF | 166 | Q460N5 | |
| LETLSGLVDSNLNCG | 146 | O14559 | |
| FTLSPSGLEDQLLGQ | 3346 | Q9P2D7 | |
| LIQLTGQSFSTDAAG | 231 | P10398 | |
| LALSSSKGEFLLNGN | 796 | Q9P2N4 | |
| LSATEAQLVAFLQGL | 41 | Q8IV32 | |
| DDSGNNGVILFSILR | 956 | Q9BYE9 | |
| TSGESFSLLQLIAND | 456 | A0AVF1 | |
| SSDNNDLTIGQLGLT | 81 | P27352 | |
| ISGLRFETQLGTLAQ | 126 | P22460 | |
| GTSESLLDNLGNDLS | 16 | Q96DR5 | |
| SGLVGLLEQAAELFS | 1726 | Q8NF50 | |
| GFTQSLLLDDAGSVL | 696 | Q8WTW3 | |
| LLFVLDSSESIGLQN | 616 | P12109 | |
| STLELQENGLAGLSA | 321 | Q9BQI3 | |
| TAEATTNLGLLTFGL | 406 | Q9Y6R7 | |
| LLESGNFGCSQEILS | 496 | Q9H5Z1 | |
| DTSFSLQLSQDGLQL | 1801 | O75417 | |
| LLNDDLIVSTGFGSG | 1341 | P01031 | |
| GGINLTVSLASTNLD | 1436 | Q8IZJ3 | |
| GLQELNSGIISLLSD | 51 | Q9BT40 | |
| QLSLGNALFTDLVVD | 126 | P05154 | |
| ADIIFLIDGSNNTGS | 241 | P12111 | |
| ILSTLLAIGNFLNGT | 1086 | Q2V2M9 | |
| LGELSLILNQGECSS | 546 | Q5VWK5 | |
| IFELLGSNSEGVTDL | 11 | Q6B9Z1 | |
| SLIAALTIGGQQLFS | 21 | Q5JW98 | |
| AEQTLGSGLDSFELI | 401 | Q5TEA3 | |
| DLSGTDISNEGLNVL | 536 | Q8NEE6 | |
| TSSGLLNASAQIFGI | 461 | Q9Y5Y0 | |
| LTNSLFGNSGILENV | 16 | Q8TEP8 | |
| EEDSFLLLQQSVALG | 21 | Q92837 | |
| LLLQQSVALGSSGEV | 26 | Q92837 | |
| TGTEFSQELRQLVGL | 266 | Q15051 | |
| SILFQSSGLTNGIIE | 451 | Q9BVP2 | |
| SGLLNSLGALTELQF | 211 | P40197 | |
| GGLGTESQDSILDFL | 66 | Q9UIH9 | |
| ILDFLLSQATLGSGG | 76 | Q9UIH9 | |
| GLVDGLFLLRDSQSN | 511 | Q13322 | |
| AGVTIQDTLNTLDGL | 1091 | Q13753 | |
| SFLSGVNIQIVGDDL | 306 | P13929 | |
| SGSALQALQGELSEV | 636 | Q9Y6C2 | |
| NVLLDFTGGSFSLLQ | 301 | O60931 | |
| SGNFLGETVLVENLE | 3631 | Q9NYC9 | |
| EQSIISLENLVFGAG | 201 | Q49AJ0 | |
| LATLLAVGNFLNGSQ | 821 | Q9Y613 | |
| GTSLNESSLQGIILE | 416 | Q9BQA5 | |
| GSLFNTIQALIDEGD | 136 | Q6YP21 | |
| INIGTTLGLLQFDSN | 596 | Q86V97 | |
| LLLQQSVTLGSSGEV | 26 | O75474 | |
| GTANLESLTLTGAQI | 326 | O75473 | |
| SSSGQFEGNLLELSD | 1266 | Q5VU65 | |
| GFTGNDLVAITSALN | 306 | P51513 | |
| IFLGLSDSQELQTFL | 6 | Q96R69 | |
| DQDLGQADSLLFSSL | 56 | Q8N2Y8 | |
| DGIQLANELGSLFLE | 161 | Q6T310 | |
| LQDLSGIELGLAGQS | 861 | Q8N1F8 | |
| GFDALDQLSQVELLG | 311 | Q9BT81 | |
| FLLLNDSNTTVLGGE | 46 | Q9H7E2 | |
| FQGLDSLESLLLSSN | 121 | Q8TF66 | |
| NAGILLISGLQSEDE | 96 | A0A087WSX0 | |
| FSLDGNINLTELTLA | 331 | Q8N4C6 | |
| SLFLLSSDGQNVVGI | 316 | Q5VVP1 | |
| SGQQVAVDLFLLSGQ | 681 | O95486 | |
| LGLGSLITELTANEE | 71 | Q8IZX4 | |
| ILEGLGFNLTELSES | 101 | P29622 | |
| LGLTDNAELQVTLFG | 31 | P0C617 | |
| SLFLLSSDGQNVVGI | 316 | Q8IWB4 | |
| LVSGTQLSQLIEGLD | 686 | Q92859 | |
| LQDFDTLLLSGDGNT | 61 | Q9H3S1 | |
| LIASGANLLAVNTDG | 156 | Q96I34 | |
| TSIAQLFAENGNLGI | 261 | Q8IUQ4 | |
| LFAENGNLGINVTIS | 266 | Q8IUQ4 | |
| LFADNGNLGINVTIS | 306 | O43255 | |
| LAQLFSDNGSLAIGI | 241 | Q8IW03 | |
| LQAVVDSLQGGLDSS | 196 | Q9Y4R8 | |
| LGQLLGEQESFESSL | 786 | Q8TF17 | |
| DQNGIISTLLGSNDL | 1381 | Q9NT68 | |
| ASSFVFLNLLGQLTG | 66 | O15260 | |
| FGEADALLQVLQSGT | 4221 | Q9P2P6 | |
| ALLQVLQSGTGEALA | 4226 | Q9P2P6 | |
| TTGTGFLDRQELTQL | 21 | Q9Y2I6 | |
| GVLNDTLVIFTSDNG | 261 | P51688 | |
| LADFGVAGQLTDTQI | 156 | O00506 | |
| SGLLLTFIGQESTGQ | 1231 | Q6Q759 | |
| FLGSSEGLDFQTLLL | 61 | O95025 | |
| LALLSQSLLTTGNGD | 11 | Q70Z44 | |
| QSLLTTGNGDTLIIN | 16 | Q70Z44 | |
| LNTQGCTTEGDLLFA | 106 | Q8N365 | |
| LGSNLLKIDSSNELG | 151 | Q9BXN2 | |
| TENLQSLTEGLLGAT | 76 | Q969H4 | |
| LELLTITGDGFDSQS | 151 | Q3C1V1 | |
| LSLLDLGSNALEDNG | 801 | Q7RTR0 | |
| ENGLSLILFGLTQEE | 486 | Q96JI7 | |
| SLFLLSSDGQNVVGI | 316 | Q5VYP0 | |
| LGLNGDFSVLNTLLN | 1366 | Q63HN8 | |
| TILSGDQGFLELENQ | 976 | Q9Y4E5 | |
| EIDLLSSTLAELNGG | 96 | Q15654 | |
| LLDSGSVENVLQVGF | 186 | Q9P217 | |
| SLFLLSSDGQNAVGI | 316 | Q5TZJ5 | |
| SLFLLSSDGQNVVGI | 316 | Q5VU36 | |
| DSTLQQLALHFLGGS | 236 | Q9UBI4 | |
| AQANTSALILEGLGF | 91 | Q86U17 | |
| SALILEGLGFNLTET | 96 | Q86U17 | |
| GLTNILNLEADFSGV | 331 | Q86U17 | |
| LNLEADFSGVTGQLN | 336 | Q86U17 | |
| IEALTIQGDNLFSGS | 1546 | Q7Z4S6 | |
| SLLNGGLQEEELSTS | 226 | O95235 | |
| FTLNGELLITNKGSE | 1161 | Q15413 | |
| GDISNSSELLLGFNS | 21 | Q96MS0 | |
| GLVTFATQLFNLLSG | 216 | Q7Z404 | |
| FDDGGLLQTETTLGL | 76 | Q92545 | |
| SQGLEGLLSGSELQS | 206 | Q6ZS81 | |
| GFNGLLSLLSDLEGS | 646 | Q6ZS81 | |
| GTSTGAAINFALEQL | 571 | Q6UXI7 | |
| LFQQDATLSGLVNLG | 831 | Q12968 | |
| NIGLLDNLLFGSIIS | 221 | P19634 | |
| SDLLILDFGTFQLNS | 711 | Q709C8 | |
| LALDQSLSLSVDGGN | 1246 | O94813 | |
| SGGVLSLELQLNASS | 81 | A6NDV4 | |
| QGSLNSSASLDLGFL | 261 | O43566 | |
| LNTLAEDLLSSGTFN | 1666 | P02549 | |
| EDTASSQLGFGVLEL | 161 | Q12888 | |
| SQLGFGVLELSQSQD | 166 | Q12888 | |
| LGLTLQSLTVNDTGE | 91 | Q495A1 | |
| TALDGENSSGLQQLA | 561 | Q92543 | |
| FFSSVDGQLELLAQG | 291 | Q9UPN7 | |
| DGQLELLAQGALEST | 296 | Q9UPN7 | |
| TLSRNLELGLTQGSF | 151 | Q9UK55 | |
| GDLLQSFGVLAASIL | 241 | Q99726 | |
| GNTTVISLLLEAGAN | 236 | Q8IUH5 | |
| GELASLGQELQAITT | 1251 | O43379 | |
| TGLSTQGLLIFAELI | 276 | Q96K49 | |
| DGSLATLEGIQLQLA | 1351 | Q9UL36 | |
| ATAALTAGQLTFLLG | 106 | Q9BSN7 | |
| LFANLEELTQTSLGF | 336 | Q6ZR37 | |
| DNVGNGFLSLLQVAT | 1126 | Q01118 | |
| SFSGTLLQIFEDNLL | 1021 | Q9BTW9 | |
| QTQSLLGLSSEGLLE | 1186 | Q5VWN6 | |
| QLGDLGLEQFSVSEL | 666 | Q92508 | |
| SQELLQAGATLGTEA | 2196 | Q9C0G0 | |
| GLITQALLTGNFESA | 571 | O94979 | |
| VVGSESGSFLQLLLE | 26 | Q6P3X3 | |
| AGEGTLSEALLQLQF | 431 | Q04206 | |
| SNLLDLLTEVGVSGQ | 296 | Q9H3U1 | |
| LQDTFLVTDQDAGLL | 2166 | O75962 | |
| GLFLVATGSQQSLAQ | 21 | Q6UXU0 | |
| DGAFLGQSSLQVLQL | 96 | Q5R3F8 | |
| GSLNNIADGLSSLTE | 96 | Q8N2G6 | |
| SGNVSLLFNGSLLLQ | 1341 | P82987 | |
| VTNLANSSLGFILAD | 96 | P38571 | |
| GLDSLTNVDLRGNSF | 161 | O95970 | |
| LLTLTQGEENLFETG | 186 | O75113 | |
| GSAFLQLGVSLEQQL | 136 | Q14957 |